The Maybridge portfolio offers a comprehensive range of chemistry products and services tailored to the drug discovery and biotechnology sector. For 45 years, Maybridge has been at the forefront of innovative heterocyclic building block design, fuelled by the desire to access novel molecules of pharmaceutical interest.